Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy…
<!-- Name:DistributionId Value:8846911 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
ovarian
Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio…
<!-- Name:DistributionId Value:8845840 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
IN8bio’s DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer
<!-- Name:DistributionId Value:8841106 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
World Ovarian Cancer Day: Raising Awareness and Promoting Prevention Strategies
The symptoms of ovarian cancer are often vague and can be easily mistaken for other conditions. They include bloating, abdominal or , difficulty eating or feeling full quickly, and urinary…
Financial Toxicity of Ovarian Cancer Treatment for Patients
Financial burdens can negatively affect the quality of life for individuals with ovarian cancer, according…
Sobering OS Data With Maintenance Niraparib in Recurrent Ovarian Cancer
Niraparib (Zejula) maintenance did not improve overall survival (OS) in patients with platinum-sensitive…
Early Data on Neoadjuvant Olaparib in Ovarian Cancer
Neoadjuvant treatment with olaparib (Lynparza) prior to surgical resection and adjuvant chemotherapy was…
Better Survival for Ovarian Cancer Patients Who Join Clinical Trials
Patients with platinum-resistant epithelial ovarian cancer who participate in clinical trials may have…
Ovarian Cancer Drugs Market Size to Grow by US$ 9,857 Mn by 2032, Driven by…
<!-- Name:DistributionId Value:8807783 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy
TAMPA, Fla. -- As lines of therapy increased for recurrent ovarian cancer, so did the risk of venous thromboembolism (VTE), a…